ScoMed
The Future of Pharmacovigilance Is Here
Key features:
Unmatched intelligence and Accuracy in Signal Detection:
ScoMed’s advanced AI scans thousands of global data sources to spot potential safety risks before they escalate. From FDA reports and Health Canada to social media chatter such as Twitter/X, LinkedIn, Facebook etc. ScoMed ensures no signal is overlooked, giving real-time insights that help make proactive, data-driven decisions.
Comprehensive Data Integration for Complete Visibility:
With access to a wealth of data—from Publically accessible sources, social media platforms, and global regulatory databases—ScoMed provides a holistic view of a drug’s safety profile. Whether it’s an adverse event reported in a tweet or a rare side effect emerging in a study, ScoMed consolidates it all in one platform, ensuring nothing slips through the cracks.
Stay Compliant with Global Standards:
Navigating the complexities of global pharmacovigilance regulations can be daunting. ScoMed simplifies this by automatically aligning with FDA, Health Canada standards and many more, helping users stay compliant with the latest regulatory changes—without the hassle.
Predictive Analytics for Proactive Safety Management:
ScoMed doesn’t just detect safety signals—it anticipates future risks by analyzing both historical and real-time data. Going beyond individual reports, it identifies long-term trends, enabling users to spot recurring safety signals or risks that may not be immediately obvious. With its advanced predictive analytics, ScoMed helps to forecast potential issues, plan interventions, and allocate resources proactively—before problems even arise.
Seamless integration with Argus, ArisG and other safety databases
Effortlessly connects with industry-standard safety systems to enable unified, complaint, and real-time signal management.